Pfizer has revealed what it will charge for a five-day course of its oral antiviral Paxlovid for COVID-19 when it starts to see it on the commercial market later this year. The drugmaker has set a ...

US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant.

Basically, Paxlovid was unsafe for a whole bunch of patients. So for the last couple of years scientists at Pfizer have been doing some nifty chemistry, tweaking the nirmatrelvir molecule in the ...

Paxlovid — Pfizer’s combination of nirmatrelvir and ritonavir — has been found to reduce symptoms, hospitalizations and deaths in unvaccinated, at-risk patients. However, a Pfizer trial ...

What do you do? Specifically, what's the role of antivirals? You might have heard about a drug called Paxlovid. Well, Paxlovid is a pill that you take by mouth, as opposed to some other therapies ...

However, Pfizer does have challenges ahead. Sales of the company’s Covid-19 products are much less than they were amid the pandemic. Sales of Comirnaty and Paxlovid were about $11 billion in ...

REUTERS/Jennifer Lorenzini Brazil's highest health authority approved on Wednesday the emergency use of Paxlovid, the drug developed by US pharmaceutical company Pfizer to treat COVID-19.

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla ... COVID vaccine Comirnaty and COVID antiviral Paxlovid, Bourla felt the pinch as his pay dropped ...